Market Entry and Reimbursement: Making Drugs Available for Patients After Drug Approval (English)
- New search for: Bechara, Ahmad
- New search for: Haroun, Rola
- New search for: Hinder, Markus
- New search for: Schuhmacher, Alexander
- New search for: Goldhahn, Jörg
- New search for: Hartl, Dominik
- New search for: Bechara, Ahmad
- New search for: Haroun, Rola
In:
Principles of Biomedical Sciences and Industry
: Translating Ideas into Treatments
;
225-245
;
2022
-
ISBN:
- Article/Chapter (Book) / Electronic Resource
-
Title:Market Entry and Reimbursement: Making Drugs Available for Patients After Drug Approval
-
Contributors:Hinder, Markus ( editor ) / Schuhmacher, Alexander ( editor ) / Goldhahn, Jörg ( editor ) / Hartl, Dominik ( editor ) / Bechara, Ahmad ( author ) / Haroun, Rola ( author )
-
Published in:Principles of Biomedical Sciences and Industry : Translating Ideas into Treatments ; 225-245
-
Publisher:
- New search for: Wiley‐VCH GmbH
-
Place of publication:Weinheim, Germany
-
Publication date:2022-10-03
-
Size:21 pages
-
ISBN:
-
DOI:
-
Type of media:Article/Chapter (Book)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents eBook
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Biopharmaceutical Innovation at a GlanceHinder, Markus / Hartl, Dominik / Schuhmacher, Alexander et al. | 2022
- 7
-
Pharmacology and Drug Targets – The Basis of TherapeuticsHartl, Lena / Fink, Martin A. / Beer‐Hammer, Sandra et al. | 2022
- 37
-
Principles and Methods of the Pharmaceutical Drug Discovery Process – From Idea over Target to a Development CandidateKramer, Werner et al. | 2022
- 63
-
Biomarkers: Definitions and Utility for Drug DevelopmentHartl, Dominik et al. | 2022
- 81
-
Toxicology in Drug Development – Understanding a Drug's Toxicity and Managing Safety and RisksRosner, Elisabeth et al. | 2022
- 99
-
Introduction to Chemistry Manufacturing and Controls – From Compound and Development Candidate to DrugEichinger, Thomas et al. | 2022
- 119
-
Translational Medicine – The Bridging Discipline. Role and Tools in the Drug Development ProcessHinder, Markus / Hartl, Dominik et al. | 2022
- 139
-
Decision‐Making: What are the Key Drivers Around Decision‐Making in Drug Development?McCracken, Nigel et al. | 2022
- 151
-
Clinical Drug Development – Clinical Characterization for Regulatory ApprovalSeiz, Werner et al. | 2022
- 177
-
Regulatory Affairs – Communicating with Health AuthoritiesFuelle, Hans‐Juergen / Lanctin, Valerie et al. | 2022
- 203
-
Regulatory Affairs in Device Development – How to Design Medical Devices Capable to Enter the MarketSchaffarczyk, Dietmar et al. | 2022
- 225
-
Market Entry and Reimbursement: Making Drugs Available for Patients After Drug ApprovalBechara, Ahmad / Haroun, Rola et al. | 2022
- 247
-
Pricing in Germany – Key Learnings for Optimizing Price Potential After the Introduction of AMNOGJones, Jacqueline et al. | 2022
- 257
-
Project, Risk, and Portfolio Management – Managing R & D Projects Today*Schuhmacher, Alexander / Hinder, Markus et al. | 2022
- 281
-
Intellectual Property – How to Protect Innovation in the Biopharmaceutical IndustryJeffries, Charles E. / Larbig, Karen D. et al. | 2022
- 305
-
Patents in the Biomedical Sciences and Industry – The Case of the S wiss L ife S cience C ompany P rionicsBader, Martin A. / Gassmann, Oliver et al. | 2022
- 317
-
Pharmaceutical Business Development and Licensing – Overview of a Cross‐Functional and Multifaceted Role and Its Key Elements in Biopharmaceutical IndustrySchuessler, Monika et al. | 2022
- 333
-
The Entrepreneur's Guide Through the Galaxy of Biotech FundingSchmidt, Mathias et al. | 2022
- 345
-
Medical Technologies – Key Learning from Two Case StudiesLorenz, Günter / Schüle, Andreas et al. | 2022
- 357
-
Laboratory Diagnostics – Tools for Clinical Decision‐Making and Clinical Trial EndpointsAgrawal, Bhuwnesh et al. | 2022
- 377
-
Vaccination: Towards an Improved Influenza VaccineMorgon, Pierre A. et al. | 2022
- 397
-
Index| 2022
- i
-
Front Matter| 2022